Mosley Wealth Management’s AbbVie ABBV Stock Holding History

Mosley Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$489K	Sell	1,944 -419	-18%	-$90.1K	0.16%	98
2026 Q1	$547K	Sell	2,363 -1	-0%	-$222	0.25%	83
2025 Q4	$547K	Buy	+2,364	New	+$539K	0.25%	91
2024 Q4	$343K	Sell	1,957 -2,031	-51%	-$373K	0.21%	91
2024 Q3	$744K	Buy	3,988 +253	+7%	+$47.2K	0.51%	42
2024 Q2	$641K	Sell	3,735 -93	-2%	-$15.4K	0.55%	39
2024 Q1	$697K	Sell	3,828 -78	-2%	-$13.4K	0.65%	34
2023 Q4	$605K	Buy	+3,906	New	+$569K	0.6%	36

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Mosley Wealth Management's ABBV Position: Q2 2026 in Review

Mosley Wealth Management reduced its AbbVie (ABBV) stake by 18% in Q2 2026, selling an estimated $90.1K and leaving 1,944 shares worth $489K. The position accounts for 0.16% of the portfolio, ranked #98.

Mosley Wealth Management first reported a position in ABBV in Q4 2023 and has held it in 8 quarters since. The position peaked at $744K in Q3 2024. 2,786 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Mosley Wealth Management held 1,944 shares of AbbVie worth $489K as of Q2 2026.
Mosley Wealth Management sold 419 AbbVie shares in Q2 2026, an estimated $90.1K.
AbbVie made up 0.16% of Mosley Wealth Management's portfolio in Q2 2026, its #98 holding.
Mosley Wealth Management first reported a position in AbbVie in Q4 2023 and has held it in 8 quarters since.
Mosley Wealth Management's AbbVie position peaked at $744K in Q3 2024.
2,786 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Mosley Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.